These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16707884)

  • 1. Primary focal hyperhidrosis: disease characteristics and functional impairment.
    Hamm H; Naumann MK; Kowalski JW; Kütt S; Kozma C; Teale C
    Dermatology; 2006; 212(4):343-53. PubMed ID: 16707884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life.
    Solish N; Benohanian A; Kowalski JW;
    Dermatol Surg; 2005 Apr; 31(4):405-13. PubMed ID: 15871315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of axillary hyperhidrosis by chemodenervation of sweat glands using botulinum toxin type A.
    Glaser DA
    J Drugs Dermatol; 2004; 3(6):627-31. PubMed ID: 15624745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival.
    Campanati A; Sandroni L; Gesuita R; Giuliano A; Giuliodori K; Marconi B; Ganzetti G; Offidani A
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):917-21. PubMed ID: 21054569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey.
    Strutton DR; Kowalski JW; Glaser DA; Stang PE
    J Am Acad Dermatol; 2004 Aug; 51(2):241-8. PubMed ID: 15280843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of focal axillary hyperhidrosis using a long-pulsed Nd:YAG 1064 nm laser at hair reduction settings.
    Letada PR; Landers JT; Uebelhoer NS; Shumaker PR
    J Drugs Dermatol; 2012 Jan; 11(1):59-63. PubMed ID: 22206078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of quality of life in patients with primary axillary hyperhidrosis before and after suction-curettage.
    Bechara FG; Gambichler T; Bader A; Sand M; Altmeyer P; Hoffmann K
    J Am Acad Dermatol; 2007 Aug; 57(2):207-12. PubMed ID: 17368632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
    Lowe NJ; Glaser DA; Eadie N; Daggett S; Kowalski JW; Lai PY;
    J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily pattern of sweating and response to stress and exercise in patients with palmar hyperhidrosis.
    Krogstad AL; Mork C; Piechnik SK
    Br J Dermatol; 2006 Jun; 154(6):1118-22. PubMed ID: 16704643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
    Güleç AT
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
    Heckmann M; Ceballos-Baumann AO; Plewig G;
    N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Focal hyperhidrosis: disease characteristics and treatments].
    Campanelli A; Salomon D
    Rev Med Suisse; 2009 Apr; 5(200):870-5. PubMed ID: 19438086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life after thoracoscopic sympathectomy for palmar hyperhidrosis.
    Kumagai K; Kawase H; Kawanishi M
    Ann Thorac Surg; 2005 Aug; 80(2):461-6. PubMed ID: 16039186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumescent suction curettage versus minimal skin resection with subcutaneous curettage of sweat glands in axillary hyperhidrosis.
    Wollina U; Köstler E; Schönlebe J; Haroske G
    Dermatol Surg; 2008 May; 34(5):709-16. PubMed ID: 18318727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective sweat gland removal with minimal skin excision in the treatment of axillary hyperhidrosis: a retrospective clinical and histological review of 15 patients.
    Lawrence CM; Lonsdale Eccles AA
    Br J Dermatol; 2006 Jul; 155(1):115-8. PubMed ID: 16792762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diode laser hair removal does not interfere with botulinum toxin A treatment against axillary hyperhidrosis.
    Paul A; Kranz G; Schindl A; Kranz GS; Auff E; Sycha T
    Lasers Surg Med; 2010 Mar; 42(3):211-4. PubMed ID: 20333738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uniportal endoscopic thoracic sympathectomy for treatment of palmar and axillary hyperhidrosis: analysis of 2000 cases.
    Lin TS; Kuo SJ; Chou MC
    Neurosurgery; 2002 Nov; 51(5 Suppl):S84-7. PubMed ID: 12234434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the patient presenting with hyperhidrosis.
    Solish N; Wang R; Murray CA
    Thorac Surg Clin; 2008 May; 18(2):133-140. PubMed ID: 18557587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M; Lowe NJ; Kumar CR; Hamm H;
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superiority of thoracoscopic sympathectomy over medical management for the palmoplantar subset of severe hyperhidrosis.
    Baumgartner FJ; Bertin S; Konecny J
    Ann Vasc Surg; 2009; 23(1):1-7. PubMed ID: 18619780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.